Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NEDD8-activating enzyme E1 regulatory subunit (NAE1) is the regulatory component of the E1 heterodimeric enzyme complex (with UBA3) that catalyzes the first step in activation of NEDD8, a ubiquitin-like protein. This activation, termed neddylation, is essential for regulating cell cycle progression, viability, cell growth, and DNA repair mechanisms. NAE1 binds the amyloid precursor protein and has been implicated in neuronal functions and in the pathogenesis of Alzheimer’s disease, as well as in cancer where inhibition of NAE1 is being clinically pursued. Pevonedistat, an NAE inhibitor, blocks neddylation and impairs DNA repair and cell cycle progression, particularly in cancer cells. Overexpression of NAE1 leads to deregulated cell cycle and apoptosis, underlining its role as a mechanistically and therapeutically relevant target in oncology, neurobiology, and cellular homeostasis
Inhibition of NEDD8-activating enzyme, leading to disruption of neddylation, impaired protein degradation, and cell cycle arrest; Pevonedistat forms an inhibitory covalent adduct with NEDD8 in the NAE active site, blocking the enzyme’s activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NEDD8-activating enzyme E1 regulatory subunit (NAE1).